Candel Therapeutics, Inc.CADLNASDAQ
Loading
P/E Ratio HistoryNormalizing
Percentile Rank17
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-7.84
↓ 19% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive declineNormalizing
Average
-6.60
Historical baseline
PeriodValueYoY Change
2025-7.84-57.3%
2024-4.98-344.4%
2023-1.12+59.2%
2022-2.75+55.8%
2021-6.21+16.2%
2020-7.41+53.4%
2019-15.90-